Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Benign lung tumors: Presentation, diagnosis, and outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Approach to hypersensitivity reactions to chemotherapeutics in patients with lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Rare primary pulmonary tumors Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Primary pulmonary sarcomatoid carcinoma: A case series Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Pulmonary tuberculosis and lung cancer: A complex interaction Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment? Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Cetuximab administered through pulmonary route in a mice model of lung tumor Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013
Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC) Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014
Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016